The week can be summed up pretty succinctly by just saying AI and biotech.
Venture
The numbers don’t lie — or in the very least they tell a clearer story than the prevalent “AI will save the world” narrative.
Indonesia-based aquaculture startup eFishery raised $108 million in a Series D, launching the company into narwhal — uh, unicorn status.
Worldcoin developer Tools For Humanity — co-founded by OpenAI’s Sam Altman — raised a $115 million Series C led by Blockchain Capital.
Despite some recent debt rounds from well-known startups that garnered headlines, VC-backed startups in the U.S. have raised about $5.5 billion on...
Turkey-based AI marketing platform Insider locked up another $105 million and plans to use the new cash for M&A dealmaking.
ElevateBio, a Massachusetts-based gene therapy startup, announced $401 million in Series D funding.
![Illustration of man and robot looking at each other. [Dom Guzman]](https://news.crunchbase.com/wp-content/uploads/AI_robotics_Facing-470x352.jpg)
Later-stage investment in AI is hopping with ChatGPT rival Anthropic's Series C and software development platform Builder.ai's Series D.
Some of those sky-high unicorn valuations now seem as real as unicorns.
Following his layoff, tech worker Anmol Sahai took the chance to found a workflow software startup for in-house legal teams.
We used Crunchbase data to look at how some venture-backed AI companies that went public on U.S. exchanges in the past three years are faring.
67.1K Followers